"Following strong interest from institutional and sophisticated investors, the Directors havealso resolved to issue a portion of the oversubscriptions, totalling commitments ofapproximately $3,004,166 (being 30,041,660 Shares) as a placement under the Company’sListing Rule 7.1 capacity (on equal terms as the Entitlement Offer). The additional fundsraised will be allocated to the Company’s working capital, to be utilised in accordancewith the Company’s existing project development strategy."
They don't have to be a ex-holders
- Forums
- ASX - By Stock
- AGY
- Ann: Appendix 3B
Ann: Appendix 3B, page-51
-
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGY (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.95M |
Open | High | Low | Value | Volume |
3.6¢ | 3.6¢ | 3.5¢ | $148.5K | 4.241M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 277877 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.6¢ | 477816 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 277877 | 0.035 |
20 | 2415124 | 0.034 |
13 | 1395935 | 0.033 |
6 | 823000 | 0.032 |
3 | 504333 | 0.031 |
Price($) | Vol. | No. |
---|---|---|
0.036 | 477816 | 6 |
0.037 | 1772505 | 13 |
0.038 | 1243900 | 6 |
0.039 | 1569010 | 9 |
0.040 | 1220475 | 6 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online